• CanaFarma Hemp Products (CSE:CNFA) has announced that it is developing a hemp oil-infused product line for skincare
  • The skincare line’s first product is a facial cream infused with hemp oil, which treats the symptoms of acne 
  • The formulation uses cannabinoid properties to combat acne characteristics, including bacteria, inflammation and oil production
  • The company expects to launch the acne cream product by the end of 2020’s second quarter
  • CanaFarma is up 5.00 per cent, and is currently trading for C$0.84 per share

CanaFarma Hemp Products (CSE:CNFA) has announced that it is developing a hemp oil-infused product line for skincare.

The company’s research and division team has produced the skincare line’s first product, a hemp oil-infused facial cream. CanaFarma designed the cream to treat the skin conditions and various symptoms related to acne. 

Acne Vulgaris is a skin disease which impacts a large portion of the population. It is especially prolific in teenagers, afflicting 79 to 95 per cent of them during puberty.

While it is most associated with adolescence, acne can continue well into adulthood. Roughly 40 to 54 per cent of people over the age of 25 have some degree of facial acne. Even in middle age, 12 per cent of women and three per cent of men can have it. 

In a society which continues to perpetuate the struggle with physical beauty standards, acne can cause serious psychological issues.

CanaFarma’s formulation uses hemp oil’s cannabinoid properties to combat characteristics of acne. These include bacteria, inflammation and excessive oil production.

Sebocytes are the cells which create sebum, and can cause acne when they overproduce the oily substance that clogs pores. A 2014 study showed that cannabinoids prevented the cells from creating too much sebum, allowing the skin to remain unclogged.

The same study also showed that active cannabinoids helped to reduce inflammation, which can be painful and unsightly in acne.

A 2016 review of hemp also highlighted its antibacterial and antifungal effects. This may help to reduce infections from dirt and other pollutants, which can contribute to acne.

CanaFarma has been developing the acne treatment formulation with Carl Germano. He is a clinical nutritionist, an expert in cannabinoid product development, and Vice President of hemp oil company Verdant Oasis.

CanaFarma’s CEO, David Lonsdale, commented on the company’s medical application of cannabis formulations.

“Medical Science is only just beginning to understand the benefits of Hemp Oil and the cannabinoids that it contains. CanaFarma is committed to delivering quality science-based products targeted towards specific benefits to the consumer. 

“I am delighted to be announcing our Acne Cream and look forward to it being available to our customers,” he said.

CanaFarma is up 5.00 per cent, and is trading for C$0.84 per share as of 11:22am EDT.

More From The Market Online

Tilray Brands seeks US$250M for U.S. cannabis expansion

Global cannabis stock Tilray Brands (TSX:TLRY) intends to raise up to US$250 million to fund its U.S. expansion plan.

The Market Online’s Weekly Cannabis Report – May 17, 2024

This international biopharmaceutical company revealed it has completed the retrospective observational real-world evidence study.

Avicanna finishes study of CBD cream’s use for rare skin disorder

Avicanna (TSX:AVCN) completes an observational study of its RHO Phyto-branded Ultra CBD topical cream on patients with epidermolysis bullosa.